Trial Profile
2-STEP: A single-centre, phase II study to evaluate the safety, tolerability and pharmacokinetics of 2-Iminobiotin (2-IB) in neonates with gestational age of ≥36 weeks with moderate to severe perinatal asphyxia treated with therapeutic hypothermia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2018
Price :
$35
*
At a glance
- Drugs 2-iminobiotin (Primary)
- Indications Asphyxia
- Focus Adverse reactions; Pharmacokinetics
- Acronyms 2-STEP
- 19 Sep 2017 Status changed from not yet recruiting to completed.
- 29 Apr 2015 New trial record